Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to investigate whether percutaneous Patent Foramen Ovale (PFO) closure, using the AMPLATZER PFO Occluder, is superior to current standard of care medical treatment in the prevention of recurrent embolic stroke.


Clinical Trial Description

The AMPLATZER PFO Occluder is a percutaneous, transcatheter occlusion device intended for the non-surgical closure of patent foramen ovale in subjects who have had a cryptogenic stroke due to presumed paradoxical embolism within the last 270 days. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT00465270
Study type Interventional
Source Abbott Medical Devices
Contact
Status Completed
Phase N/A
Start date August 2003
Completion date May 2016

See also
  Status Clinical Trial Phase
Completed NCT04198220 - BIO|STREAM.ICM Obesity
Enrolling by invitation NCT06398366 - Cardiac Abnormalities in Stroke Prevention and Risk of Recurrence
Recruiting NCT03803969 - ConfirmRxTM: Posture and Activity N/A
Recruiting NCT05529901 - Japan Post Marketing Surveillance of the GORE® CARDIOFORM Septal Occluder
Recruiting NCT04075084 - Observation of Clinical Routine Care for Patients With BIOTRONIK Implantable Cardiac Monitors (ICMs)
Recruiting NCT04285918 - Evaluation of Prevalence and Clinical Impact of Atrial Fibrillation in Elderly Patients With Cryptogenic Stroke and High-Risk Patent Foramen Ovale
Completed NCT04025710 - Master Study of the BIOMONITOR III and Incision and Insertion Tool (FIT OneStep) N/A
Recruiting NCT05006105 - Early Detection of Atrial Fibrillation Using Mobile Technology in Cryptogenic Stroke Patients N/A
Completed NCT04732728 - LUX-Dx Insertable Cardiac Monitor Remote Programming and Performance Study
Recruiting NCT04881578 - Atrial Fibrillation Before and After Patent Foramen Ovale Closure Study
Recruiting NCT05565781 - Smartwatch and External Holter Monitoring to Detect Atrial Fibrillation in Patients With Cryptogenic Stroke N/A
Active, not recruiting NCT05213104 - Assessment of Flecainide to Lower the Patent Foramen Ovale Closure Risk of Atrial Arrhythmia or Tachycardia Phase 3
Recruiting NCT00861133 - Cryptogenic Stroke Study N/A
Completed NCT04206774 - BIO|STREAM.ICM France
Recruiting NCT05774288 - Safety and Efficacy of Cera™ Patent Foramen Ovale Occluders. N/A
Recruiting NCT05537753 - Encore PFO Closure Device - The PerFOrm Trial N/A
Active, not recruiting NCT02374359 - Atrial Tachycardia as a Predictor of Atrial Fibrillation, Stroke and Mortality in Cryptogenic Stroke N/A
Recruiting NCT05007847 - Improving AF Detection in Cryptogenic Stroke N/A
Recruiting NCT05486221 - Atrial Imaging and Cardiac Rhythm In Embolic Stroke
Active, not recruiting NCT05907694 - Medical Treatment With or Without Transcatheter Patent Foramen Ovale Closure N/A